Autolus grants options and RSUs to director

Autolus Therapeutics plc director Rao Madduri Ravin received new equity awards in the form of options and restricted share units tied to American Depositary Shares.

Rhea-AI Filing Summary

Autolus Therapeutics plc director Rao Madduri Ravin received new equity awards in the form of options and restricted share units tied to American Depositary Shares. The grant includes 47,500 share options with a $1.61 exercise price expiring on June 29, 2036, and 31,667 restricted share units. The RSUs vest in a single installment on June 29, 2027, while the options vest in twelve equal monthly installments starting on July 29, 2026. These awards represent compensation-related acquisitions rather than open-market purchases or sales.

Insider Trade Summary

Grant/Award: 79,167 shares

Grant/Award 2 txns

Insider Rao Madduri Ravin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	31,667	$0.00	$0.00
Grant/Award	Share Option (Right to Buy)	47,500	$0.00	$0.00

Holdings After Transaction: Restricted Share Units — 31,667 contracts (Direct); Share Option (Right to Buy) — 47,500 contracts (Direct)

Footnotes (3)

1. F1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.
2. F2. The RSUs vest in one installment on June 29, 2027.
3. F3. Share options vest in twelve equal monthly installments commencing on July 29, 2026.

Key Figures

Options granted: 47,500 options Option exercise price: $1.61 per share Option expiration: June 29, 2036 +3 more

6 metrics

Options granted 47,500 options Grant dated June 29, 2026

Option exercise price $1.61 per share Share Option (Right to Buy)

Option expiration June 29, 2036 Expiration date of options

RSUs granted 31,667 RSUs Grant dated June 29, 2026

RSU vesting date June 29, 2027 Single vesting installment

Option vesting schedule 12 equal monthly installments Commencing July 29, 2026

Key Terms

Restricted Share Units, Share Option (Right to Buy), American Depositary Shares, vest

4 terms

Restricted Share Units financial

"The RSUs vest in one installment on June 29, 2027."

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

Share Option (Right to Buy) financial

"Share Option (Right to Buy) with a $1.61 exercise price."

American Depositary Shares financial

"Each restricted stock unit represents a contingent right to receive one share of the Issuer's American Depositary Shares."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

vest financial

"Share options vest in twelve equal monthly installments commencing on July 29, 2026."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

What equity awards did Autolus Therapeutics (AUTL) grant to Rao Madduri Ravin?

Autolus Therapeutics granted director Rao Madduri Ravin 47,500 share options and 31,667 restricted share units. The options carry a $1.61 exercise price, and both awards relate to the company’s American Depositary Shares as part of equity-based compensation.

When do the new Autolus Therapeutics (AUTL) RSUs granted to Rao Madduri Ravin vest?

The 31,667 restricted share units granted to Rao Madduri Ravin vest in one installment on June 29, 2027. Once vested, each RSU entitles the holder to receive one American Depositary Share of Autolus Therapeutics, subject to applicable plan terms.

What is the vesting schedule for Rao Madduri Ravin’s new Autolus (AUTL) stock options?

Rao Madduri Ravin’s 47,500 Autolus share options vest in twelve equal monthly installments starting July 29, 2026. This means a portion becomes exercisable each month over one year, providing gradual access to the options rather than immediate full vesting.

What is the exercise price and expiration date of the Autolus (AUTL) options granted to Rao Madduri Ravin?

The options granted to Rao Madduri Ravin have a $1.61 exercise price per American Depositary Share and expire on June 29, 2036. After expiration, any unexercised options become void and can no longer be converted into shares.

How do the new RSUs and options in Autolus (AUTL) relate to its American Depositary Shares?

Each RSU represents a right to receive one American Depositary Share of Autolus, and each option allows purchase of one ADS at the set exercise price. Each ADS is convertible into one Ordinary Share, linking these awards directly to the company’s underlying equity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rao Madduri Ravin

(Last) (First) (Middle)

THE MEDIAWORKS, WHITE CITY

C/O AUTOLUS THERAPEUTICS PLC

(Street)

LONDON W12 7FP

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Autolus Therapeutics plc [ AUTL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	06/29/2026		A		31,667		(2)	(2)	American Depositary Shares	31,667	$0	31,667	D
Share Option (Right to Buy)	$1.61	06/29/2026		A		47,500		(3)	06/29/2036	American Depositary Shares	47,500	$0	47,500	D

Explanation of Responses:

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.

2. The RSUs vest in one installment on June 29, 2027.

3. Share options vest in twelve equal monthly installments commencing on July 29, 2026.

	/s/ Madduri Ravin Rao	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)